13F manager/FATE/

Robert Bruce (Bruce & Co) trim Fate Therapeutics, Inc.

Robert Bruce (Bruce & Co) trim $577.5K of disclosed value in Fate Therapeutics, Inc..

Signal
Investor Move
Action
Trim
Capital
$577.5K disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence